Maternal antibiotic treatment protects offspring from diabetes development in nonobese diabetic mice by generation of tolerogenic APCs

Journal of Immunology

Volumn 195, Issue 9, 2015, Pages 4176-4184

  Hu, Youjia ^a   Peng, Jian ^a   Tai, Ningwen ^a   Hu, Changyun ^a   Zhang, Xiaojun ^a   Wong, F Susan ^b   Wen, Li ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; NEOMYCIN; POLYMYXIN B; STREPTOMYCIN; ANTIINFECTIVE AGENT;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; GRAM NEGATIVE BACTERIUM; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE FLORA; MOUSE; NEWBORN; NEWBORN PERIOD; NONHUMAN; NONOBESE DIABETIC MOUSE; PRENATAL PERIOD; PRIORITY JOURNAL; PROGENY; PROTEIN FUNCTION; AGE; ANIMAL; ANTIGEN PRESENTING CELL; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; IMMUNOLOGY; INTESTINE; MICROBIOLOGY; MICROFLORA; PHYSIOLOGY; PREGNANCY; T LYMPHOCYTE;

AGE FACTORS; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIGEN-PRESENTING CELLS; DIABETES MELLITUS, TYPE 1; FEMALE; IMMUNE TOLERANCE; INTESTINES; MICE; MICE, INBRED NOD; MICROBIOTA; NEOMYCIN; POLYMYXIN B; PREGNANCY; STREPTOMYCIN; T-LYMPHOCYTES;

EID: 84945143926     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500884     Document Type: Article

References (39)

1. Redondo, M. J., L. Yu, M. Hawa, T. Mackenzie, D. A. Pyke, G. S. Eisenbarth, and R. D. Leslie. 2001. Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia 44: 354-362.
2. Metcalfe, K. A., G. A. Hitman, R. E. Rowe, M. Hawa, X. Huang, T. Stewart, and R. D. Leslie. 2001. Concordance for type 1 diabetes in identical twins is affected by insulin genotype. Diabetes Care 24: 838-842.
3. Babaya, N., M. Nakayama, and G. S. Eisenbarth. 2005. The stages of type 1A diabetes. Ann. N. Y. Acad. Sci. 1051: 194-204.
4. Marcovecchio, M. L., P. H. Tossavainen, and D. B. Dunger. 2010. Prevention and treatment of microvascular disease in childhood type 1 diabetes. Br. Med. Bull. 94: 145-164.
5. Patterson, C. C., E. Gyürüs, J. Rosenbauer, O. Cinek, A. Neu, E. Schober, R. C. Parslow, G. Joner, J. Svensson, C. Castell, et al. 2012. Trends in childhood type 1 diabetes incidence in Europe during 1989-2008: evidence of nonuniformity over time in rates of increase. Diabetologia 55: 2142-2147.
6. Brown, C. T., A. G. Davis-Richardson, A. Giongo, K. A. Gano, D. B. Crabb, N. Mukherjee, G. Casella, J. C. Drew, J. Ilonen, M. Knip, et al. 2011. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS One 6: e25792.
7. Cerf-Bensussan, N., and V. Gaboriau-Routhiau. 2010. The immune system and the gut microbiota: friends or foes? Nat. Rev. Immunol. 10: 735-744.
8. King, C., and N. Sarvetnick. 2011. The incidence of type-1 diabetes in NOD mice is modulated by restricted flora not germ-free conditions. PLoS One 6: e17049.
9. Manirarora, J. N., S. A. Parnell, Y. H. Hu, M. M. Kosiewicz, and P. Alard. 2011. NOD dendritic cells stimulated with Lactobacilli preferentially produce IL-10 versus IL-12 and decrease diabetes incidence. Clin. Dev. Immunol. 2011: 630187.
10. Round, J. L., and S. K. Mazmanian. 2009. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 9: 313-323.
11. Valladares, R., D. Sankar, N. Li, E. Williams, K. K. Lai, A. S. Abdelgeliel, C. F. Gonzalez, C. H. Wasserfall, J. Larkin, D. Schatz, et al. 2010. Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. PLoS One 5: e10507.
12. Wen, L., R. E. Ley, P. Y. Volchkov, P. B. Stranges, L. Avanesyan, A. C. Stonebraker, C. Hu, F. S. Wong, G. L. Szot, J. A. Bluestone, et al. 2008. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455: 1109-1113.
13. Atkinson, M. A., and A. Chervonsky. 2012. Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease. Diabetologia 55: 2868-2877.
14. Couturier-Maillard, A., T. Secher, A. Rehman, S. Normand, A. De Arcangelis, R. Haesler, L. Huot, T. Grandjean, A. Bressenot, A. Delanoye-Crespin, et al. 2013. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J. Clin. Invest. 123: 700-711.
15. Duca, F. A., Y. Sakar, P. Lepage, F. Devime, B. Langelier, J. Doré, and M. Covasa. 2014. Replication of obesity and associated signaling pathways through transfer of microbiota from obese-prone rats. Diabetes 63: 1624-1636.
16. Hara, N., A. K. Alkanani, D. Ir, C. E. Robertson, B. D. Wagner, D. N. Frank, and D. Zipris. 2013. The role of the intestinal microbiota in type 1 diabetes. Clin. Immunol. 146: 112-119.
17. Pachikian, B. D., A. M. Neyrinck, L. Deldicque, F. C. De Backer, E. Catry, E. M. Dewulf, F. M. Sohet, L. B. Bindels, A. Everard, M. Francaux, et al. 2010. Changes in intestinal bifidobacteria levels are associated with the inflammatory response in magnesium-deficient mice. J. Nutr. 140: 509-514.
18. Boerner, B. P., and N. E. Sarvetnick. 2011. Type 1 diabetes: role of intestinal microbiome in humans and mice. Ann. N. Y. Acad. Sci. 1243: 103-118.
19. Cénit, M. C., V. Matzaraki, E. F. Tigchelaar, and A. Zhernakova. 2014. Rapidly expanding knowledge on the role of the gut microbiome in health and disease. Biochim. Biophys. Acta 1842: 1981-1992.
20. Myles, I. A., N. M. Fontecilla, B. M. Janelsins, P. J. Vithayathil, J. A. Segre, and S. K. Datta. 2013. Parental dietary fat intake alters offspring microbiome and immunity. J. Immunol. 191: 3200-3209.
21. Woese, C. R. 1987. Bacterial evolution. Microbiol. Rev. 51: 221-271.
22. Levine, D. P. 2006. Vancomycin: a history. Clin. Infect. Dis. 42(Suppl 1): S5-S12.
23. Hansen, C. H., L. Krych, D. S. Nielsen, F. K. Vogensen, L. H. Hansen, S. J. Sørensen, K. Buschard, and A. K. Hansen. 2012. Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse. Diabetologia 55: 2285-2294.
24. Kriegel, M. A., E. Sefik, J. A. Hill, H. J. Wu, C. Benoist, and D. Mathis. 2011. Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc. Natl. Acad. Sci. USA 108: 11548-11553.
25. Lau, K., P. Benitez, A. Ardissone, T. D. Wilson, E. L. Collins, G. Lorca, N. Li, D. Sankar, C. Wasserfall, J. Neu, et al. 2011. Inhibition of type 1 diabetes correlated to a Lactobacillus johnsonii N6.2-mediated Th17 bias. J. Immunol. 186: 3538-3546.
26. Satoh, J., S. Shintani, K. Oya, S. Tanaka, T. Nobunaga, T. Toyota, and Y. Goto. 1988. Treatment with streptococcal preparation (OK-432) suppresses anti-islet autoimmunity and prevents diabetes in BB rats. Diabetes 37: 1188-1194.
27. Saï, P., and A. S. Rivereau. 1996. Prevention of diabetes in the nonobese diabetic mouse by oral immunological treatments. Comparative efficiency of human insulin and two bacterial antigens, lipopolysacharide from Escherichia coli and glycoprotein extract from Klebsiella pneumoniae. Diabetes Metab. 22: 341-348.
28. Dixon, R. A., and I. Chopra. 1986. Polymyxin B and polymyxin B nonapeptide alter cytoplasmic membrane permeability in Escherichia coli. J. Antimicrob. Chemother. 18: 557-563.
29. Singh, B., and D. A. Mitchison. 1954. Bactericidal activity of streptomycin and isoniazid against tubercle bacilli. BMJ 1: 130-132.
30. Obojska, K., and A. K. Drabikowska. 1981. Studies on the mechanism of resistance of Pseudomonas aeruginosa to neomycin. II. Correlation between neomycin resistance and hemoprotein concentration. Acta Microbiol. Pol. 30: 123-131.
31. Kallionpää, H., E. Laajala, V. Öling, T. Härkönen, V. Tillmann, N. V. Dorshakova, J. Ilonen, H. Lähdesmäki, M. Knip, and R. Lahesmaa, DIABIMMUNE Study Group. 2014. Standard of hygiene and immune adaptation in newborn infants. Clin. Immunol. 155: 136-147.
32. Brugman, S., F. A. Klatter, J. T. Visser, A. C. Wildeboer-Veloo, H. J. Harmsen, J. Rozing, and N. A. Bos. 2006. Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 49: 2105-2108.
33. Tormo-Badia, N., Å. Håkansson, K. Vasudevan, G. Molin, S. Ahrné, and C. M. Cilio. 2014. Antibiotic treatment of pregnant non-obese diabetic mice leads to altered gut microbiota and intestinal immunological changes in the offspring. Scand. J. Immunol. 80: 250-260.
34. Hansen, C. H., L. Krych, K. Buschard, S. B. Metzdorff, C. Nellemann, L. H. Hansen, D. S. Nielsen, H. Frøkiær, S. Skov, and A. K. Hansen. 2014. A maternal gluten-free diet reduces inflammation and diabetes incidence in the offspring of NOD mice. Diabetes 63: 2821-2832.
35. Salminen, S., G. R. Gibson, A. L. McCartney, and E. Isolauri. 2004. Influence of mode of delivery on gut microbiota composition in seven year old children. Gut 53: 1388-1389.
36. de Goffau, M. C., K. Luopajärvi, M. Knip, J. Ilonen, T. Ruohtula, T. Härkönen, L. Orivuori, S. Hakala, G. W. Welling, H. J. Harmsen, and O. Vaarala. 2013. Fecal microbiota composition differs between children with β-cell autoimmunity and those without. Diabetes 62: 1238-1244.
37. Murri, M., I. Leiva, J. M. Gomez-Zumaquero, F. J. Tinahones, F. Cardona, F. Soriguer, and M. I. Queipo-Ortuño. 2013. Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Med. 11: 46.
38. Cardwell, C. R., L. C. Stene, G. Joner, O. Cinek, J. Svensson, M. J. Goldacre, R. C. Parslow, P. Pozzilli, G. Brigis, D. Stoyanov, et al. 2008. Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies. Diabetologia 51: 726-735.
39. Dominguez-Bello, M. G., E. K. Costello, M. Contreras, M. Magris, G. Hidalgo, N. Fierer, and R. Knight. 2010. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl. Acad. Sci. USA 107: 11971-11975.